JP2021518379A5 - - Google Patents

Info

Publication number
JP2021518379A5
JP2021518379A5 JP2020550114A JP2020550114A JP2021518379A5 JP 2021518379 A5 JP2021518379 A5 JP 2021518379A5 JP 2020550114 A JP2020550114 A JP 2020550114A JP 2020550114 A JP2020550114 A JP 2020550114A JP 2021518379 A5 JP2021518379 A5 JP 2021518379A5
Authority
JP
Japan
Prior art keywords
methyl
pyrimidine
pyrrolo
azaspiro
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020550114A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021518379A (ja
JP7462951B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/022657 external-priority patent/WO2019182924A1/en
Publication of JP2021518379A publication Critical patent/JP2021518379A/ja
Publication of JP2021518379A5 publication Critical patent/JP2021518379A5/ja
Application granted granted Critical
Publication of JP7462951B2 publication Critical patent/JP7462951B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020550114A 2018-03-21 2019-03-18 Jak阻害剤 Active JP7462951B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862646167P 2018-03-21 2018-03-21
US62/646,167 2018-03-21
PCT/US2019/022657 WO2019182924A1 (en) 2018-03-21 2019-03-18 Jak inhibitors

Publications (3)

Publication Number Publication Date
JP2021518379A JP2021518379A (ja) 2021-08-02
JP2021518379A5 true JP2021518379A5 (cg-RX-API-DMAC7.html) 2022-03-30
JP7462951B2 JP7462951B2 (ja) 2024-04-08

Family

ID=67986579

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020550114A Active JP7462951B2 (ja) 2018-03-21 2019-03-18 Jak阻害剤

Country Status (7)

Country Link
US (1) US11365188B2 (cg-RX-API-DMAC7.html)
EP (1) EP3768272B1 (cg-RX-API-DMAC7.html)
JP (1) JP7462951B2 (cg-RX-API-DMAC7.html)
CN (1) CN111936144B (cg-RX-API-DMAC7.html)
AU (1) AU2019237991B2 (cg-RX-API-DMAC7.html)
CA (1) CA3093706A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019182924A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102218333B1 (ko) 2016-06-07 2021-02-22 자코바이오 파마슈티칼스 컴퍼니 리미티드 Shp2 억제제로서 유용한 신규한 헤테로환형 유도체
SG11201908820VA (en) 2017-03-23 2019-10-30 Jacobio Pharmaceuticals Co Ltd Novel heterocyclic derivatives useful as shp2 inhibitors
CN112839935A (zh) 2018-09-26 2021-05-25 北京加科思新药研发有限公司 可用作shp2抑制剂的新型杂环衍生物
JP2022506682A (ja) * 2018-11-05 2022-01-17 アビスタ ファーマ ソリューションズ,インコーポレーテッド 化合物
CN113498352A (zh) 2019-01-23 2021-10-12 施万生物制药研发Ip有限责任公司 作为jak抑制剂的咪唑并[1,5-a]吡啶、1,2,4-三唑并[4,3-a]吡啶和咪唑并[1,5-a]吡嗪
DK3915989T3 (da) 2019-01-30 2023-09-18 Felicamed Biotechnology Co Ltd Jak inhibitor and preparation method therefor
TW202227452A (zh) * 2020-12-04 2022-07-16 大陸商廣州費米子科技有限責任公司 氮雜並環化合物、其製備方法、抑制酪氨酸激酶的方法、藥物組成物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6075736B2 (ja) 2011-12-21 2017-02-08 ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co.,Ltd. ピロール−6員ヘテロアリール環誘導体、その合成法およびその医薬用途
LT3077395T (lt) 2013-12-05 2018-02-12 Pfizer Inc. Pirolo[2,3-d]pirimidinilo, pirolo[2,3-b]pirazinilo ir pirolo[2,3-d]piridinilo akrilamidai
US9340540B2 (en) 2014-02-28 2016-05-17 Nimbus Lakshmi, Inc. TYK2 inhibitors and uses thereof
WO2016024185A1 (en) * 2014-08-12 2016-02-18 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase
ES2962330T3 (es) 2015-01-20 2024-03-18 Wuxi Fortune Pharmaceutical Co Ltd Inhibidor de jak
WO2018169700A1 (en) 2017-03-14 2018-09-20 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use

Similar Documents

Publication Publication Date Title
AU2016328619B2 (en) Heterocyclic compounds and uses thereof
EP3468972B1 (en) Compounds and compositions for inhibiting the activity of shp2
JP6695353B2 (ja) Fgfr4阻害剤としてのホルミル化n−複素環式誘導体
TWI579284B (zh) 咪唑并吡咯啶酮化合物
JP2024522345A (ja) ウェルナー症候群RecQヘリカーゼ(WRN)の阻害に関連する疾患を治療するためのトリアゾロ-ピリミジン類似体
CN118974055A (zh) 作为突变kras蛋白抑制剂的喹唑啉化合物及其用途
JP2013523884A5 (cg-RX-API-DMAC7.html)
JP2013515070A5 (cg-RX-API-DMAC7.html)
AU2017286654A1 (en) Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
JP2025536259A (ja) 三環式化合物及びその使用
EP3710002A2 (en) Degraders and degrons for targeted protein degradation
HRP20140770T1 (hr) SUPSTITUIRANI SPOJEVI N-(1H-INDAZOL-4-IL)IMIDAZO[1,2-a]PIRIDIN-3-KARBOKSAMIDA KAO INHIBITORI CFMS
EP4237086A1 (en) Heterocyclic spiro compounds and methods of use
CN108430993A (zh) Tank-结合激酶抑制剂化合物
RU2013136778A (ru) Ингибиторы гистондезацетилазы, композиции и способы их применения
JP2024536858A5 (cg-RX-API-DMAC7.html)
JP2012515737A (ja) メトトレキサートおよびdhodh阻害剤を含む組合せ剤
CN111051305A (zh) 治疗性杂环化合物
CA2904797A1 (en) Combination of an egfr t790m inhibitor and an egfr inhibitor for the treatment of non-small cell lung cancer
JP2006512366A5 (cg-RX-API-DMAC7.html)
EP3994132A1 (en) Tyrosine kinase non-receptor 1 (tnk1) inhibitors and uses thereof
JP2021514011A5 (cg-RX-API-DMAC7.html)
RU2015102537A (ru) Цианогуанидины и их применение в качестве противовирусных средств
RU2014105177A (ru) Новое соединение, проявляющее ингибиторную активность в отношении parp
RU2006138606A (ru) Ингибиторы киназы